Trial Profile
A Nationwide, Multicenter, Retrospective Study of Efficacy and Safety of Infliximab Therapy and Predictors of Response in Korean Patients with Crohn's Disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Apr 2017
Price :
$35
*
At a glance
- Drugs Infliximab (Primary)
- Indications Crohn's disease
- Focus Adverse reactions; Therapeutic Use
- 18 Apr 2017 New trial record